Abstract: OBJECTIVE: To observe the therapeutic effects of the mixture of adriamycin liposome (Lip - ADM ) and lipiodol administered into the hepatic artery for the model of W256 liver cancer in rats and compare it with that of adrimycin (ADM) solution and ADM plus